The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a ...
We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...
ACV Auctions (NASDAQ:ACVA – Get Free Report) was upgraded by stock analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research report issued on Thursday, Marketbeat ...
Scotiabank analyst Patrick Colville has initiated coverage of Microsoft (MSFT) stock with a Buy rating and a $470 price ...
AI-driven chipmaker Nvidia (NVDA) wrapped up its GTC 2025 conference on Friday, after a week of groundbreaking announcements and expert ...
Some investors have hoped that first-quarter earnings could provide a catalyst for gains in the market after the sharp ...
The integration of Clinical Data Studio into ICON's service offerings helps unlock the full potential of the Medidata Data Experience, merging information from both Medidata and non-Medidata sources, ...
Data science is one of the few fields resilient to the current federal budget pauses and reductions, says data scientist ...
A three-judge panel for the Court of Appeals for the District of Columbia Circuit unanimously agreed with the Copyright ...
The IPO may end up being less of a big deal than CoreWeave’s new $12 billion deal with AI heavyweight OpenAI, analysts at investment bank Canaccord Genuity suggested in a March 12 note.
an analyst at TD Cowen said this week. That might not seem obvious right now. Musk helms a company besieged by a flurry of headwinds: Depressed sales data, Wall Street downgrades, and rising EV ...
3d
Clinical Trials Arena on MSNIcon integrates Medidata’s Clinical Data Studio into clinical studiesIcon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results